A Multi-ethnic Proteomic Profiling Analysis in Alzheimer's Disease Identifies the Disparities in Dysregulation of Proteins and Pathogenesis

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2024 Jul 22

PMID 39035156

Authors

Mei Sze Tan

Phaik-Leng Cheah

Ai-Vyrn Chin

Lai-Meng Looi

Siow-Wee Chang

Affiliations

Soon will be listed here.

Abstract

Background: Alzheimer's disease (AD) is the most common type of dementia that affects the elderly population. Lately, blood-based proteomics have been intensively sought in the discovery of AD biomarkers studies due to the capability to link external environmental factors with the development of AD. Demographic differences have been shown to affect the expression of the proteins in different populations which play a vital role in the degeneration of cognitive function.

Method: In this study, a proteomic study focused on Malaysian Chinese and Malay prospects was conducted. Differentially expressed proteins (DEPs) in AD patients and normal controls for Chinese and Malays were identified. Functional enrichment analysis was conducted to further interpret the biological functions and pathways of the DEPs. In addition, a survey investigating behavioural practices among Chinese and Malay participants was conducted to support the results from the proteomic analysis.

Result: The variation of dysregulated proteins identified in Chinese and Malay samples suggested the disparities of pathways involved in this pathological condition for each respective ethnicity. Functional enrichment analysis supported this assumption in understanding the protein-protein interactions of the identified protein signatures and indicate that differentially expressed proteins identified from the Chinese group were significantly enriched with the functional terms related to Aβ/tau protein-related processes, oxidative stress and inflammation whereas neuroinflammation was associated with the Malay group. Besides that, a significant difference in sweet drinks/food intake habits between these two groups implies a relationship between sugar levels and the dysregulation of protein in the Malay group. Additional meta-analysis further supported the dysregulation of proteins , , and among AD groups.

Conclusion: These findings serve as a preliminary understanding in the molecular and demographic studies of AD in a multi-ethnic population.

References

Prokopenko D, Morgan S, Mullin K, Hofmann O, Chapman B, Kirchner R . Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development. Alzheimers Dement. 2021; 17(9):1509-1527. PMC: 8519060. DOI: 10.1002/alz.12319. View

Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A . ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009; 25(8):1091-3. PMC: 2666812. DOI: 10.1093/bioinformatics/btp101. View

Smith E, Nilforooshan R, Weaving G, Tabet N . Plasma fetuin-A is associated with the severity of cognitive impairment in mild-to-moderate Alzheimer's disease. J Alzheimers Dis. 2011; 24(2):327-33. DOI: 10.3233/JAD-2011-101872. View

Llano D, Devanarayan V, Simon A . Evaluation of plasma proteomic data for Alzheimer disease state classification and for the prediction of progression from mild cognitive impairment to Alzheimer disease. Alzheimer Dis Assoc Disord. 2012; 27(3):233-43. DOI: 10.1097/WAD.0b013e31826d597a. View

Yao F, Zhang K, Zhang Y, Guo Y, Li A, Xiao S . Identification of Blood Biomarkers for Alzheimer's Disease Through Computational Prediction and Experimental Validation. Front Neurol. 2019; 9:1158. PMC: 6331438. DOI: 10.3389/fneur.2018.01158. View

Zhang Z, Song G . Roles of Selenoproteins in Brain Function and the Potential Mechanism of Selenium in Alzheimer's Disease. Front Neurosci. 2021; 15:646518. PMC: 7982578. DOI: 10.3389/fnins.2021.646518. View

Jiang R, Smailovic U, Haytural H, Tijms B, Li H, Haret R . Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosis. Acta Neuropathol Commun. 2022; 10(1):96. PMC: 9254429. DOI: 10.1186/s40478-022-01398-5. View

Du X, Zheng Y, Wang Z, Chen Y, Zhou R, Song G . Inhibitory act of selenoprotein P on Cu(+)/Cu(2+)-induced tau aggregation and neurotoxicity. Inorg Chem. 2014; 53(20):11221-30. DOI: 10.1021/ic501788v. View

Vowinkel T, Mori M, Krieglstein C, Russell J, Saijo F, Bharwani S . Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest. 2004; 114(2):260-9. PMC: 450164. DOI: 10.1172/JCI21233. View

10.

Abdullah N, Teo P, Foo L . Ethnic Differences in the Food Intake Patterns and Its Associated Factors of Adolescents in Kelantan, Malaysia. Nutrients. 2016; 8(9). PMC: 5037536. DOI: 10.3390/nu8090551. View

11.

Bishnoi R, Palmer R, Royall D . Vitamin D binding protein as a serum biomarker of Alzheimer's disease. J Alzheimers Dis. 2014; 43(1):37-45. DOI: 10.3233/JAD-140042. View

12.

Bian Z, Yamashita T, Shi X, Feng T, Yu H, Hu X . Accelerated accumulation of fibrinogen peptide chains with Aβ deposition in Alzheimer's disease (AD) mice and human AD brains. Brain Res. 2021; 1767:147569. DOI: 10.1016/j.brainres.2021.147569. View

13.

Shafinaz I, Moy F . Vitamin D level and its association with adiposity among multi-ethnic adults in Kuala Lumpur, Malaysia: a cross sectional study. BMC Public Health. 2016; 16:232. PMC: 4780132. DOI: 10.1186/s12889-016-2924-1. View

14.

Solovyev N . Selenoprotein P and its potential role in Alzheimer's disease. Hormones (Athens). 2019; 19(1):73-79. DOI: 10.1007/s42000-019-00112-w. View

15.

Kononikhin A, Zakharova N, Semenov S, Bugrova A, Brzhozovskiy A, Indeykina M . Prognosis of Alzheimer's Disease Using Quantitative Mass Spectrometry of Human Blood Plasma Proteins and Machine Learning. Int J Mol Sci. 2022; 23(14). PMC: 9318764. DOI: 10.3390/ijms23147907. View

16.

Wu B, Qiao J, Wang X, Liu M, Xu S, Sun D . Factors affecting the rapid changes of protein under short-term heat stress. BMC Genomics. 2021; 22(1):263. PMC: 8042900. DOI: 10.1186/s12864-021-07560-y. View

17.

Nielsen J, Honore B, Vestergard K, Maltesen R, Christiansen G, Boge A . Shotgun-based proteomics of extracellular vesicles in Alzheimer's disease reveals biomarkers involved in immunological and coagulation pathways. Sci Rep. 2021; 11(1):18518. PMC: 8445922. DOI: 10.1038/s41598-021-97969-y. View

18.

Mucke L . Neuroscience: Alzheimer's disease. Nature. 2009; 461(7266):895-7. DOI: 10.1038/461895a. View

19.

Rehiman S, Lim S, Neoh C, Majeed A, Chin A, Tan M . Proteomics as a reliable approach for discovery of blood-based Alzheimer's disease biomarkers: A systematic review and meta-analysis. Ageing Res Rev. 2020; 60:101066. DOI: 10.1016/j.arr.2020.101066. View

20.

Francois M, Karpe A, Liu J, Beale D, Hor M, Hecker J . Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer's Disease. Metabolites. 2022; 12(10). PMC: 9610280. DOI: 10.3390/metabo12100949. View